company background image
IOT

Innovotech TSXV:IOT Stock Report

Last Price

CA$0.17

Market Cap

CA$6.4m

7D

0%

1Y

0%

Updated

29 Jun, 2022

Data

Company Financials
IOT fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends0/6

IOT Stock Overview

Innovotech Inc. provides solutions to medical, agricultural, and industrial problems caused by microbial biofilms in Canada, the United States, and internationally.

Innovotech Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Innovotech
Historical stock prices
Current Share PriceCA$0.17
52 Week HighCA$0.23
52 Week LowCA$0.12
Beta1.32
1 Month Change10.00%
3 Month Change-13.16%
1 Year Change0%
3 Year Change153.85%
5 Year Change73.68%
Change since IPO-21.43%

Recent News & Updates

Mar 02
Would Financials Be Able To Push Innovotech Inc.'s (CVE:IOT) Stock Prices Higher In The Near Future?

Would Financials Be Able To Push Innovotech Inc.'s (CVE:IOT) Stock Prices Higher In The Near Future?

Looking at Innovotech's (CVE:IOT) mostly flat share price movement over the past week, it is easy to think that there’s...

Shareholder Returns

IOTCA Life SciencesCA Market
7D0%-9.9%0.3%
1Y0%-18.0%-3.7%

Return vs Industry: IOT exceeded the Canadian Life Sciences industry which returned -19% over the past year.

Return vs Market: IOT exceeded the Canadian Market which returned -2.9% over the past year.

Price Volatility

Is IOT's price volatile compared to industry and market?
IOT volatility
IOT Average Weekly Movementn/a
Life Sciences Industry Average Movement11.4%
Market Average Movement10.0%
10% most volatile stocks in CA Market17.2%
10% least volatile stocks in CA Market4.4%

Stable Share Price: Insufficient data to determine IOT's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine IOT's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2001n/aJames Timourianhttps://www.innovotech.ca

Innovotech Inc. provides solutions to medical, agricultural, and industrial problems caused by microbial biofilms in Canada, the United States, and internationally. The company offers InnovoSIL, an antimicrobial agents for coating onto or incorporation into medical devices; MBEC Assay, a screening assay used to determine the efficacy of antimicrobials against biofilms of various microorganisms; and AgreGuard, an antimicrobial for crop protection. It also provides implant medical devices; antibiotic, antimicrobial, and biocide resistance; biofilm eradication surface and MBEC Assay testing; and analytical services.

Innovotech Fundamentals Summary

How do Innovotech's earnings and revenue compare to its market cap?
IOT fundamental statistics
Market CapCA$6.42m
Earnings (TTM)CA$312.61k
Revenue (TTM)CA$1.45m

20.5x

P/E Ratio

4.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
IOT income statement (TTM)
RevenueCA$1.45m
Cost of RevenueCA$373.75k
Gross ProfitCA$1.08m
Other ExpensesCA$763.49k
EarningsCA$312.61k

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.008
Gross Margin74.22%
Net Profit Margin21.56%
Debt/Equity Ratio0%

How did IOT perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is IOT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for IOT?

Other financial metrics that can be useful for relative valuation.

IOT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue4.1x
Enterprise Value/EBITDA19.1x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does IOT's PE Ratio compare to its peers?

IOT PE Ratio vs Peers
The above table shows the PE ratio for IOT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average9.2x
IBT IBEX Technologies
6.9xn/aCA$11.5m
J Lotus Ventures
12.8xn/aCA$6.3m
MPH Medicure
13.4xn/aCA$10.8m
EAST EastWest Bioscience
2.9xn/aCA$1.5m
IOT Innovotech
20.5xn/aCA$6.4m

Price-To-Earnings vs Peers: IOT is expensive based on its Price-To-Earnings Ratio (20.5x) compared to the peer average (9.2x).


Price to Earnings Ratio vs Industry

How does IOT's PE Ratio compare vs other companies in the North American Life Sciences Industry?

Price-To-Earnings vs Industry: IOT is good value based on its Price-To-Earnings Ratio (20.5x) compared to the North American Life Sciences industry average (29.7x)


Price to Earnings Ratio vs Fair Ratio

What is IOT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

IOT PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio20.5x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate IOT's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of IOT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: IOT (CA$0.17) is trading above our estimate of fair value (CA$0.03)

Significantly Below Fair Value: IOT is trading above our estimate of fair value.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate IOT's PEG Ratio to determine if it is good value.


Discover undervalued companies

Future Growth

How is Innovotech forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


11.5%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Innovotech has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Discover growth companies

  • Check out Innovotech's track record over time to understand how much the company has returned to shareholders and its earnings growth rate in the past.
  • Innovotech competitive advantages and company strategy can generally be found in its financial reports archived here.

Past Performance

How has Innovotech performed over the past 5 years?

Past Performance Score

5/6

Past Performance Score 5/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-3.0%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: IOT has a high level of non-cash earnings.

Growing Profit Margin: IOT's current net profit margins (21.6%) are higher than last year (17.7%).


Past Earnings Growth Analysis

Earnings Trend: IOT has become profitable over the past 5 years, growing earnings by -3% per year.

Accelerating Growth: IOT's earnings growth over the past year (28.2%) exceeds its 5-year average (-3% per year).

Earnings vs Industry: IOT earnings growth over the past year (28.2%) exceeded the Life Sciences industry 21.7%.


Return on Equity

High ROE: IOT's Return on Equity (27.3%) is considered high.


Discover strong past performing companies

Financial Health

How is Innovotech's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: IOT's short term assets (CA$917.2K) exceed its short term liabilities (CA$177.7K).

Long Term Liabilities: IOT's short term assets (CA$917.2K) exceed its long term liabilities (CA$14.9K).


Debt to Equity History and Analysis

Debt Level: IOT is debt free.

Reducing Debt: IOT currently has no debt however we can't compare to 5 years ago as we have no data for that period.

Debt Coverage: IOT has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: IOT has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Dividend

What is Innovotech current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate IOT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate IOT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if IOT's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if IOT's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as IOT has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

2.5yrs

Average management tenure


CEO

James Timourian

8.42yrs

Tenure

CA$13,500

Compensation

Dr. James Timourian, Ph.D. has been the President of Innovotech Inc. since January 01, 2014 and serves as its Chief Executive Officer and Secretary. Dr. Timourian has been Mathematician, President of Integ...


Leadership Team

Experienced Management: IOT's management team is considered experienced (2.5 years average tenure).


Board Members

Experienced Board: IOT's board of directors are considered experienced (5.1 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Innovotech Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Innovotech Inc.
  • Ticker: IOT
  • Exchange: TSXV
  • Founded: 2001
  • Industry: Life Sciences Tools and Services
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: CA$6.420m
  • Shares outstanding: 38.91m
  • Website: https://www.innovotech.ca

Location

  • Innovotech Inc.
  • 2011-94 Street
  • Suite L131
  • Edmonton
  • Alberta
  • T6N 1H1
  • Canada

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/29 00:00
End of Day Share Price2022/06/22 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.